MARKET

BHVN

BHVN

Biohaven
NYSE
19.10
-0.41
-2.10%
Opening 14:09 05/14 EDT
OPEN
19.69
PREV CLOSE
19.51
HIGH
20.09
LOW
18.62
VOLUME
673.85K
TURNOVER
--
52 WEEK HIGH
55.70
52 WEEK LOW
15.79
MARKET CAP
1.95B
P/E (TTM)
-2.0397
1D
5D
1M
3M
1Y
5Y
1D
Bank of America Securities Sticks to Its Buy Rating for Biohaven Ltd. (BHVN)
TipRanks · 1d ago
Biohaven price target lowered to $54 from $61 at RBC Capital
TipRanks · 1d ago
Analysts Offer Insights on Healthcare Companies: CervoMed (CRVO) and Biohaven Ltd. (BHVN)
TipRanks · 1d ago
Morgan Stanley Keeps Their Buy Rating on Biohaven Ltd. (BHVN)
TipRanks · 1d ago
RBC Capital Remains a Buy on Biohaven Ltd. (BHVN)
TipRanks · 1d ago
Analysts Offer Insights on Healthcare Companies: Evolent Health (EVH), Xenon (XENE) and Biohaven Ltd. (BHVN)
TipRanks · 1d ago
Biohaven Ltd.’s Strategic Progress and Financial Strength Bolster Buy Rating
TipRanks · 1d ago
Biohaven Ltd.’s Strong Growth Potential and Strategic Financial Backing Justifies Buy Rating
TipRanks · 1d ago
More
About BHVN
More
Biohaven Ltd. is a biopharmaceutical company focused on the discovery, development and commercialization of treatments in key therapeutic areas, including immunology, neuroscience, and oncology. It is advancing its portfolio of therapeutics, leveraging its drug development experience and multiple proprietary drug development platforms. Its clinical and preclinical programs include Kv7 ion channel modulation for epilepsy and mood disorders; extracellular protein degradation for immunological diseases; TRPM3 antagonism for migraine and neuropathic pain; TYK2/JAK1 inhibition for neuroinflammatory disorders; glutamate modulation for obsessive-compulsive disorder (OCD) and spinocerebellar ataxia (SCA); myostatin inhibition for neuromuscular and metabolic diseases, including spinal muscular atrophy (SMA) and obesity; antibody recruiting bispecific molecules; and antibody drug conjugates for cancer. Its advanced product candidate from its glutamate receptor antagonist platform is troriluzole.
Recently
Symbol
Price
%Change

Webull offers Biohaven Ltd stock information, including NYSE: BHVN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BHVN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BHVN stock methods without spending real money on the virtual paper trading platform.